1. Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents
2. . Presentation at TCT, October 25, 2006. Available at http://www.tctmd.com/csportal/appmanager/tctmd/main?_nfpb=true&_pageLabel=TCTMDContent&hdCon=1453648.
3. U.S. Food and Drug Administration Center for Devices and Radiological Health. Update to FDA statement on coronary drug-eluting stents. Available at http://www.fda.gov/cdrh/news/010407.html (updated Jan 4, 2007).
4. SCAI statement on drug-eluting stents: Practice and health care delivery implications
5. Public statement to the FDA Circulatory System Devices Panel of the Medical Devices Advisory Panel Meeting, Washington, DC, Dec 7–8, 2006. Available at http://www.scai.org/PDF/FDA%20Testimony.pdf.